The company’s successful recent innovations include:
- the Spectral CT 7500 system, which delivers high-quality spectral images for a broad patient base, including cardiac, pediatric and bariatric patients, further expanding Philips’ comprehensive CT portfolio
- new breakthrough applications for Philips’ Azurion next-generation image-guided therapy platform, helping surgeons in the interventional lab perform personalized, minimally invasive procedures
- the IntelliSite Digital Pathology Suite to enhance diagnostic confidence and workflows in pathology labs leveraging AI and cloud technologies
- the IntelliVue MX750 and MX850 patient monitors, which are uniquely designed to support scalability, alarm management, cybersecurity, and enhanced infection prevention within the hospital
- the Sonicare 9900 Prestige, a premium electric toothbrush that leverages AI to optimize the user’s brushing technique
Across the globe, Philips employs approximately 11,000 people in R&D. The company’s IP portfolio comprises 57,000 patent rights, 33,000 trademarks, 114,000 design rights and 2,900 domain names.
With a total of 1,311 patent applications at the EPO in 2021, Philips ranks ninth in the EPO’s global ranking of patent applicants. Among the EPO’s European patent applicants, Philips ranks number three,
For detailed statistics and supporting materials produced by the European Patent Office, see the EPO Patent Index 2021.